Cipla is recalling 580,451 packets of Esomeprazole Magnesium for Delayed-Release Oral Suspension (generic Nexium) in 10mg, 20mg, and 40mg doses. These prescription medications are being recalled because an inactive ingredient used during manufacturing was found to be contaminated with theophylline, an unrelated drug used to treat respiratory diseases. Consumers should contact their doctor or pharmacist immediately as taking this contaminated medication may lead to unintended side effects or drug interactions.
The product is contaminated with theophylline, a drug used for asthma and COPD. This cross-contamination can cause adverse health effects if consumers unknowingly ingest theophylline along with their prescribed esomeprazole.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.